ARGOS THERAPEUTICS INC 4
4 · ARGOS THERAPEUTICS INC · Filed Jun 14, 2016
Insider Transaction Report
Form 4
Transactions
- Award
Common Stock
2016-06-13+10,924→ 76,043 total - Award
Stock Option (right to buy)
2016-06-13+175,000→ 175,000 totalExercise: $7.41Exp: 2026-06-12→ Common Stock (175,000 underlying) - Award
Stock Option (right to buy)
2016-06-10+3,375→ 3,375 totalExercise: $6.09From: 2016-06-10Exp: 2024-07-27→ Common Stock (3,375 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units vest in twelve equal monthly installments beginning June 30, 2016. Vested shares will be delivered to the reporting person on each vesting date.
- [F2]Includes 2,002 shares of common stock acquired pursuant to the 2014 Employee Stock Purchase Plan on March 10, 2016.
- [F3]On July 28, 2014, the reporting person was granted an option to purchase 27,000 shares of common stock. This option vests in installments based on the achievement of certain performance criteria considered to be under the control or supervision of the reporting person. A performance milestone related to the non-clinical development of AGS-003 was deemed achieved by the Compensation Committee of the Company, resulting in vesting of the option with respect to 3,375 shares.
- [F4]This option was granted on June 13, 2016 and vests as to 25% of the shares underlying this option on June 13, 2017, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning June 13, 2017.